Quick Takeaways
- LQDA - Liquidia Corp has 20 insiders with reported activity on this page.
- Net insider value flow over the last year: -$69,438,313.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 20 Insiders of Liquidia Corp
- Symbol
- LQDA on Nasdaq
- Location
- Morrisville, NC
What Changed
- Buy value: ; sell value: $69,438,313.
- Net share flow: -2,214,406.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$69,438,313.
Buys
$0
Shares: 0
Insiders: 0
Sells
$69,438,313
Shares: 2,214,406
Insiders: 12
Net
-$69,438,313
Shares: -2,214,406
Insiders: -12
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 748,770 | $0 | $28,866,252 | -$28,866,252 |
| 3-6 | 0 | 352,358 | $0 | $11,774,366 | -$11,774,366 |
| 6-9 | 0 | 959,376 | $0 | $26,401,700 | -$26,401,700 |
| 9-12 | 0 | 153,902 | $0 | $2,395,995 | -$2,395,995 |
Liquidia Corp executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| David Edward Johnson | Director, Other*, 10%+ Owner | $203,277,541 | Mixed | 17 Jun 2025 | ||
| Caligan Partners LP | Director, Other*, 10%+ Owner | $153,208,230 | Mixed | 12 Sep 2024 | ||
| Roger Jeffs | Chief Executive Officer, Director | $103,761,701 | -$9,327,845 | -8.2% | Mixed | 14 Apr 2026 |
| Dr. Stephen M. Bloch | Director | $83,542,219 | -$2,533,766 | -2.9% | Mixed | 26 Mar 2026 |
| Russell Schundler | General Counsel | $25,326,143 | -$2,099,416 | -7.7% | Mixed | 10 Apr 2026 |
| Paul B. Manning | Director | $20,018,323 | -$18,957,475 | -49% | Mixed | 11 Feb 2026 |
| Michael Kaseta | CFO and COO | $15,657,620 | -$16,097,741 | -51% | Mixed | 14 Apr 2026 |
| Jason Adair | Chief Business Officer | $9,417,483 | -$2,891,448 | -23% | Mixed | 10 Apr 2026 |
| Scott Moomaw | Chief Commercial Officer | $7,987,398 | -$7,054,127 | -47% | Mixed | 10 Apr 2026 |
| Dr. Rajeev Saggar | Chief Medical Officer | $7,493,937 | -$5,313,225 | -41% | Mixed | 10 Apr 2026 |
| Dana Boyle | Chief Accounting Officer | $6,788,343 | -$1,526,049 | -18% | Filing P/S | 10 Apr 2026 |
| Sarah Krepp | Chief Human Resource Officer | $5,641,119 | -$1,384,918 | -20% | Filing P/S | 10 Apr 2026 |
| Sanjeev Khindri | Chief Development Officer | $2,457,964 | Mixed | 16 Jan 2026 | ||
| Robert A. Lippe | Chief Operations Officer | $1,606,948 | Mixed | 30 Nov 2023 | ||
| Raman Singh | Director | $1,396,784 | -$2,116,452 | -60% | Filing P/S | 13 Mar 2026 |
| Damian deGoa | Director | $1,297,065 | Mixed | 17 Jun 2025 | ||
| Arthur S. Kirsch | Director | $1,061,325 | Mixed | 17 Jun 2025 | ||
| Dr. Joanna Horobin | Director | $917,123 | -$135,850 | -13% | Filing P/S | 19 Aug 2025 |
| Katherine Rielly-Gauvin | Director | $581,325 | Mixed | 17 Jun 2025 | ||
| Dr. Tushar Shah | CMO and Head of R&D | $259,700 | Mixed | 16 Jan 2022 |
Top shareholders of Liquidia Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Farallon Capital Partners, L.P. |
13D/G
|
Dapice Joshua J. |
9.9%
|
8,656,038
|
$316,810,991 | +$3,308,640 | 31 Dec 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.9%
|
8,656,038
|
$298,546,751 | — | 31 Dec 2025 | |
| Caligan Partners LP |
13F
3/4/5
|
Company · Director, Other*, 10%+ Owner |
9.3%
|
8,118,892
|
$280,020,585 | — | 31 Dec 2025 | |
| David Edward Johnson |
3/4/5
|
Director, Other*, 10%+ Owner |
—
mixed-class rows
|
19,458,651
mixed-class rows
|
$203,277,541 | — | 17 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
6.3%
|
5,488,363
|
$189,293,640 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.6%
|
4,013,888
|
$138,438,996 | — | 31 Dec 2025 | |
| Roger Jeffs |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
2,737,195
mixed-class rows
|
$103,761,701 | -$9,327,845 | 14 Apr 2026 | |
| FINDELL CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.3%
|
2,851,449
|
$98,346,476 | — | 31 Dec 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
2.8%
|
2,435,000
|
$84,981,500 | — | 31 Dec 2025 | |
| Dr. Stephen M. Bloch |
3/4/5
|
Director |
2.6%
|
2,254,647
|
$83,542,219 | -$2,533,766 | 26 Mar 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.2%
|
1,927,420
|
$66,476,716 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,808,859
|
$62,387,547 | — | 31 Dec 2025 | |
| Caprock Group, LLC |
13F
|
Company |
2%
|
1,783,921
|
$61,527,435 | — | 31 Dec 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
2%
|
1,710,084
|
$58,980,797 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.9%
|
1,667,382
|
$57,508,005 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
1,620,811
|
$55,911,300 | — | 31 Dec 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
1.6%
|
1,400,869
|
$48,315,972 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.92%
|
800,196
|
$27,598,760 | — | 31 Dec 2025 | |
| Legend Aggregator, LP |
13D/G
|
— |
2.2%
|
1,860,371
|
$26,101,005 | $0 | 31 Dec 2024 | |
| Russell Schundler |
3/4/5
|
General Counsel |
—
mixed-class rows
|
702,561
mixed-class rows
|
$25,326,143 | -$2,099,416 | 10 Apr 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.81%
|
704,097
|
$24,284,305 | — | 31 Dec 2025 | |
| Buckley Capital Advisors, LLC |
13F
|
Company |
0.74%
|
649,386
|
$22,397,323 | — | 31 Dec 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
613,548
|
$21,161,271 | — | 31 Dec 2025 | |
| Paul B. Manning |
3/4/5
|
Director |
0.54%
|
469,583
|
$20,018,323 | -$18,957,475 | 11 Feb 2026 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.64%
|
561,745
|
$19,374,585 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.64%
|
560,829
|
$19,342,992 | — | 31 Dec 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.61%
|
532,425
|
$18,363,338 | — | 31 Dec 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.58%
|
509,443
|
$17,570,689 | — | 31 Dec 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.56%
|
486,333
|
$16,773,626 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.54%
|
473,532
|
$16,332,117 | — | 31 Dec 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.53%
|
459,766
|
$15,857,329 | — | 31 Dec 2025 | |
| Michael Kaseta |
3/4/5
|
CFO and COO |
—
mixed-class rows
|
498,577
mixed-class rows
|
$15,657,620 | -$16,097,741 | 14 Apr 2026 | |
| Invesco Ltd. |
13F
|
Company |
0.48%
|
420,621
|
$14,507,219 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.48%
|
417,638
|
$14,404,335 | — | 31 Dec 2025 | |
| Pale Fire Capital SE |
13F
|
Company |
0.43%
|
379,392
|
$13,085,230 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.43%
|
378,344
|
$13,049,092 | — | 31 Dec 2025 | |
| APIS CAPITAL ADVISORS, LLC |
13F
|
Company |
0.41%
|
355,200
|
$12,250,848 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.4%
|
350,048
|
$12,073,156 | — | 31 Dec 2025 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.38%
|
329,200
|
$11,354,108 | — | 31 Dec 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.35%
|
306,957
|
$10,586,946 | — | 31 Dec 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.32%
|
279,138
|
$9,627,470 | — | 31 Dec 2025 | |
| Jason Adair |
3/4/5
|
Chief Business Officer |
—
mixed-class rows
|
311,497
mixed-class rows
|
$9,417,483 | -$2,891,448 | 10 Apr 2026 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.3%
|
262,106
|
$9,040,036 | — | 31 Dec 2025 | |
| MIRABELLA FINANCIAL SERVICES LLP |
13F
|
Company |
0.28%
|
247,799
|
$8,546,587 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.27%
|
233,144
|
$8,041,136 | — | 31 Dec 2025 | |
| Scott Moomaw |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
246,421
mixed-class rows
|
$7,987,398 | -$7,054,127 | 10 Apr 2026 | |
| Patient Square Capital LP |
13F
|
Company |
0.26%
|
227,000
|
$7,829,230 | — | 31 Dec 2025 | |
| Dr. Rajeev Saggar |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
222,619
mixed-class rows
|
$7,493,937 | -$5,313,225 | 10 Apr 2026 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.24%
|
206,853
|
$7,134,360 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
198,693
|
$6,852,915 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for Liquidia Corp
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Roger Jeffs | LQDA | Common Stock | Sale | -1.7% | $1,007,800 | $40.31 | -25,000 | 1,441,934 | 16 Apr 2026 | See footnote |
| Roger Jeffs | LQDA | Common Stock | Sale | -1.68% | $1,003,522 | $40.14 | -25,000 | 1,466,934 | 15 Apr 2026 | See footnote |
| Michael Kaseta | LQDA | Common Stock | Options Exercise | 21.9% | 86,971 | 483,702 | 15 Apr 2026 | Direct | ||
| Michael Kaseta | LQDA | Common Stock | Sale | -28.3% | $5,595,240 | $40.14 | -139,390 | 353,356 | 15 Apr 2026 | Direct |
| Michael Kaseta | LQDA | Incentive Stock Option (right to buy) | Options Exercise | -89.2% | -86,971 | 10,534 | 15 Apr 2026 | Direct | ||
| Roger Jeffs | LQDA | Common Stock | Sale | -0.22% | $132,000 | $40.00 | -3,300 | 1,491,934 | 14 Apr 2026 | See footnote |
| Michael Kaseta | LQDA | Common Stock | Sale | -0.73% | $120,000 | $40.00 | -3,000 | 405,775 | 14 Apr 2026 | Direct |
| Michael Kaseta | LQDA | Common Stock | Options Exercise | 0.74% | 3,000 | 408,775 | 14 Apr 2026 | Direct | ||
| Michael Kaseta | LQDA | Incentive Stock Option (right to buy) | Options Exercise | -2.98% | -3,000 | 97,505 | 14 Apr 2026 | Direct | ||
| Scott Moomaw | LQDA | Common Stock | Sale | -5.41% | $404,402 | $38.34 | -10,547 | 184,558 | 13 Apr 2026 | Direct |
| Jason Adair | LQDA | Common Stock | Sale | -3.28% | $280,139 | $38.37 | -7,301 | 215,426 | 13 Apr 2026 | Direct |
| Dana Boyle | LQDA | Common Stock | Sale | -2.8% | $195,725 | $38.37 | -5,101 | 176,918 | 13 Apr 2026 | Direct |
| Michael Kaseta | LQDA | Common Stock | Sale | -4.46% | $727,418 | $38.37 | -18,958 | 405,775 | 13 Apr 2026 | Direct |
| Sarah Krepp | LQDA | Common Stock | Sale | -3.01% | $174,852 | $38.37 | -4,557 | 147,019 | 13 Apr 2026 | Direct |
| Dr. Rajeev Saggar | LQDA | Common Stock | Sale | -5.05% | $353,771 | $38.37 | -9,220 | 173,270 | 13 Apr 2026 | Direct |
| Russell Schundler | LQDA | Common Stock | Sale | -2.19% | $525,362 | $38.37 | -13,692 | 610,532 | 13 Apr 2026 | Direct |
| Roger Jeffs | LQDA | Common Stock | Sale | -2.8% | $1,256,387 | $38.37 | -32,744 | 1,137,599 | 13 Apr 2026 | Direct |
| Scott Moomaw | LQDA | Common Stock | Options Exercise | 3.98% | 7,465 | 195,105 | 10 Apr 2026 | Direct | ||
| Scott Moomaw | LQDA | Performance Stock Units | Options Exercise | -25.6% | -7,465 | 21,754 | 10 Apr 2026 | Direct | ||
| Jason Adair | LQDA | Common Stock | Options Exercise | 4.82% | 10,248 | 222,727 | 10 Apr 2026 | Direct | ||
| Jason Adair | LQDA | Performance Stock Units | Options Exercise | -26.8% | -6,342 | 17,320 | 10 Apr 2026 | Direct | ||
| Jason Adair | LQDA | Restricted Stock Units | Options Exercise | -25% | -3,906 | 11,719 | 10 Apr 2026 | Direct | ||
| Dana Boyle | LQDA | Common Stock | Options Exercise | 1.78% | 3,179 | 182,019 | 10 Apr 2026 | Direct | ||
| Dana Boyle | LQDA | Performance Stock Units | Options Exercise | -8.33% | -3,179 | 34,966 | 10 Apr 2026 | Direct | ||
| Michael Kaseta | LQDA | Common Stock | Sale | -5.47% | $956,249 | $40.14 | -23,821 | 411,855 | 10 Apr 2026 | Direct |
| Michael Kaseta | LQDA | Common Stock | Options Exercise | 9.2% | 36,699 | 435,676 | 10 Apr 2026 | Direct | ||
| Michael Kaseta | LQDA | Performance Stock Units | Options Exercise | -24% | -12,878 | 40,797 | 10 Apr 2026 | Direct | ||
| Michael Kaseta | LQDA | Incentive Stock Option (right to buy) | Options Exercise | -19.2% | -23,821 | 100,505 | 10 Apr 2026 | Direct | ||
| Sarah Krepp | LQDA | Common Stock | Options Exercise | 2.14% | 3,179 | 151,576 | 10 Apr 2026 | Direct | ||
| Sarah Krepp | LQDA | Performance Stock Units | Options Exercise | -8.33% | -3,179 | 34,966 | 10 Apr 2026 | Direct | ||
| Dr. Rajeev Saggar | LQDA | Common Stock | Options Exercise | 4.59% | 8,017 | 182,490 | 10 Apr 2026 | Direct | ||
| Dr. Rajeev Saggar | LQDA | Performance Stock Units | Options Exercise | -24.5% | -8,017 | 24,715 | 10 Apr 2026 | Direct | ||
| Russell Schundler | LQDA | Common Stock | Options Exercise | 1.66% | 10,167 | 624,224 | 10 Apr 2026 | Direct | ||
| Russell Schundler | LQDA | Performance Stock Units | Options Exercise | -27.9% | -10,167 | 26,309 | 10 Apr 2026 | Direct | ||
| Roger Jeffs | LQDA | Common Stock | Sale | -1.41% | $859,877 | $40.12 | -21,433 | 1,495,234 | 10 Apr 2026 | See footnote |
| Roger Jeffs | LQDA | Common Stock | Options Exercise | 2.47% | 28,167 | 1,170,343 | 10 Apr 2026 | Direct | ||
| Roger Jeffs | LQDA | Performance Stock Units | Options Exercise | -22.5% | -28,167 | 96,835 | 10 Apr 2026 | Direct | ||
| Roger Jeffs | LQDA | Common Stock | Sale | -1.62% | $1,002,888 | $40.12 | -25,000 | 1,516,667 | 09 Apr 2026 | See footnote |
| Michael Kaseta | LQDA | Common Stock | Sale | -24.5% | $5,383,388 | $40.24 | -133,789 | 411,855 | 09 Apr 2026 | Direct |
| Michael Kaseta | LQDA | Common Stock | Options Exercise | 32.5% | 133,789 | 545,644 | 09 Apr 2026 | Direct | ||
| Michael Kaseta | LQDA | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -114,019 | 0 | 09 Apr 2026 | Direct | ||
| Michael Kaseta | LQDA | Incentive Stock Option (right to buy) | Options Exercise | -100% | -19,770 | 0 | 09 Apr 2026 | Direct | ||
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -2.78% | $2,247,780 | $35.94 | -62,550 | 2,188,935 | 27 Mar 2026 | See footnote |
| Dr. Stephen M. Bloch | LQDA | Common Stock | Sale | -0.34% | $285,985 | $37.22 | -7,684 | 2,251,485 | 26 Mar 2026 | See footnote |
| Scott Moomaw | LQDA | Common Stock | Options Exercise | 9.06% | 17,000 | 204,640 | 23 Mar 2026 | Direct | ||
| Scott Moomaw | LQDA | Common Stock | Sale | -8.89% | $673,752 | $36.79 | -18,314 | 187,640 | 23 Mar 2026 | Direct |
| Scott Moomaw | LQDA | Incentive Stock Option (right to buy) | Options Exercise | -67.2% | -17,000 | 8,300 | 23 Mar 2026 | Direct | ||
| Dr. Rajeev Saggar | LQDA | Common Stock | Sale | -16.8% | $1,283,834 | $36.30 | -35,365 | 174,473 | 13 Mar 2026 | Direct |
| Sarah Krepp | LQDA | Common Stock | Sale | -9.88% | $617,918 | $38.00 | -16,261 | 148,397 | 13 Mar 2026 | Direct |
| Raman Singh | LQDA | Common Stock | Sale | -34% | $720,828 | $36.04 | -20,000 | 38,755 | 13 Mar 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.